Innoviva (INVA) Announces FDA Approval of XACDURO streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
24.05.2023 - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that the U.S. Food and Drug Administration (FDA) approved XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use . Seite 1